000 | 01589 a2200421 4500 | ||
---|---|---|---|
005 | 20250515073545.0 | ||
264 | 0 | _c20071019 | |
008 | 200710s 0 0 eng d | ||
022 | _a1615-9853 | ||
024 | 7 |
_a10.1002/pmic.200700108 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSchumacher, Jonathan A | |
245 | 0 | 0 |
_aProteome-wide changes induced by the Hsp90 inhibitor, geldanamycin in anaplastic large cell lymphoma cells. _h[electronic resource] |
260 |
_bProteomics _cAug 2007 |
||
300 |
_a2603-16 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xpharmacology |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aBenzoquinones _xpharmacology |
650 | 0 | 4 |
_aCaspase 3 _xmetabolism |
650 | 0 | 4 |
_aCell Cycle _xdrug effects |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aDNA, Neoplasm _xanalysis |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 |
_aHSP90 Heat-Shock Proteins _xantagonists & inhibitors |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLactams, Macrocyclic _xpharmacology |
650 | 0 | 4 |
_aLymphoma, Large B-Cell, Diffuse _xenzymology |
650 | 0 | 4 | _aModels, Biological |
650 | 0 | 4 |
_aProteome _xanalysis |
650 | 0 | 4 | _aReproducibility of Results |
700 | 1 | _aCrockett, David K | |
700 | 1 | _aElenitoba-Johnson, Kojo S J | |
700 | 1 | _aLim, Megan S | |
773 | 0 |
_tProteomics _gvol. 7 _gno. 15 _gp. 2603-16 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/pmic.200700108 _zAvailable from publisher's website |
999 |
_c17146240 _d17146240 |